Exploring wearable smart devices for patients with lung cancer after surgery
A Prospective Observational Study to the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
This study is testing how wearable smart devices can help people recover better after surgery for lung cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The First Affiliated Hospital of Guangzhou Medical University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06118229 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the role and impact of wearable smart devices in patients who have undergone surgery for non-small cell lung cancer (NSCLC). It is a single-center, non-interventional study that will collect data on how these devices can monitor patient outcomes and enhance recovery during the perioperative period. Participants will be monitored using wearable technology to gather patient-reported outcomes and other relevant health metrics. The study seeks to understand the potential benefits of integrating technology into the postoperative care of lung cancer patients.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 who have undergone pulmonary resection surgery for confirmed primary non-small cell lung cancer.
Not a fit: Patients who have a history of secondary lung cancer surgery or cannot wear monitoring devices may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve postoperative monitoring and recovery for lung cancer patients through the use of wearable technology.
How similar studies have performed: While the use of wearable devices in healthcare is gaining traction, this specific approach in perioperative NSCLC patients is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participants must provide voluntary consent to participate in this research and possess the capacity to sign an informed consent form. 2. Participants must be aged over 18 years. 3. Participants must have undergone pulmonary resection surgery with a postoperative pathological confirmation of primary lung cancer. Exclusion Criteria: 1. Patient refusal to participate in this research. 2. Inability to wear wearable smart monitoring devices due to various reasons. 3. The pathological report suggests a non-small cell lung cancer (NSCLC) exclusion. 4. History of secondary lung cancer surgery.
Where this trial is running
Guangzhou, Guangdong
- Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Principal investigator: Jianxing He, M.D — The First Affiliated Hospital of Guangzhou Medical University
- Study coordinator: Jianxing He, M.D
- Email: drjianxing.he@gmail.com
- Phone: +86-20-83337792
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.